Biochemistry may be misleading in metachronous MEN2A-associated phaeochromocytoma following unilateral total adrenalectomy

BMJ Case Rep. 2020 Jun 11;13(6):e234132. doi: 10.1136/bcr-2019-234132.

Abstract

A 63-year-old woman with multiple endocrine neoplasia type 2A (MEN2A) presented with recurrent spells of headaches, sweats and palpitations decades after right adrenalectomy for phaeochromocytoma, and total thyroidectomy for medullary thyroid cancer. She was hypertensive and in sinus rhythm. DOTA-TATE positron-emission tomography (PET) demonstrated a 12mm enhancing left adrenal incidentaloma. 24 hours urine catecholamines, and multiple plasma metanephrine and normetanephrine measurements were all within normal reference ranges. Based on her symptoms and imaging findings, left adrenalectomy was performed and found a 40 mm phaeochromocytoma. Her symptoms have since completely resolved and plasma metanephrine is now undetectable MEN2-associated phaeochromocytomas are often bilateral and may be metachronous. Patients at high risk of phaeochromocytoma who develop symptoms of catecholamine excess should be carefully evaluated even if plasma or urinary metanephrines are within the normal reference range. Biochemical reference ranges for metanephrines need to be adjusted accordingly in patients who have had prior unilateral total adrenalectomy.

Keywords: adrenal disorders; endocrine cancer; endocrinology; general surgery; surgical diagnostic tests.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Gland Neoplasms* / blood
  • Adrenal Gland Neoplasms* / diagnosis
  • Adrenal Gland Neoplasms* / physiopathology
  • Adrenal Gland Neoplasms* / surgery
  • Adrenalectomy* / adverse effects
  • Adrenalectomy* / methods
  • Carcinoma, Neuroendocrine / pathology
  • Carcinoma, Neuroendocrine / surgery
  • Diagnostic Errors / prevention & control*
  • Female
  • Humans
  • Metanephrine* / blood
  • Metanephrine* / urine
  • Middle Aged
  • Multiple Endocrine Neoplasia Type 2a* / pathology
  • Multiple Endocrine Neoplasia Type 2a* / therapy
  • Neoplasms, Second Primary* / blood
  • Neoplasms, Second Primary* / pathology
  • Neoplasms, Second Primary* / physiopathology
  • Neoplasms, Second Primary* / surgery
  • Pheochromocytoma* / blood
  • Pheochromocytoma* / diagnosis
  • Pheochromocytoma* / physiopathology
  • Pheochromocytoma* / surgery
  • Thyroid Neoplasms / pathology
  • Thyroid Neoplasms / surgery
  • Thyroidectomy / methods
  • Treatment Outcome

Substances

  • Metanephrine

Supplementary concepts

  • Adrenal incidentaloma
  • Thyroid cancer, medullary